• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Ocera Therapeutics, Inc. (OCRX)

    -NasdaqGM
    2.78 Up 0.06(2.21%) 4:00PM EST
    Prev Close:2.72
    Open:2.73
    Bid:2.78 x 200
    Ask:2.80 x 400
    1y Target Est:12.67
    Beta:2.62912
    Earnings Date:Mar 9 - Mar 14 (Est.)
    Day's Range:2.72 - 2.80
    52wk Range:2.00 - 6.57
    Volume:21,942
    Avg Vol (3m):151,890
    Market Cap:57.00M
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OCRX

    Comparison

    Symbol% ChgMkt Cap
    OCRXUp 2.21%57.00M
    IRWDUp 3.59%1.20B
    THRX 0.00%1.15B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):401.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.31
    Quarterly EPS Est (Dec-15) :-0.33
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback